Does ESKETAMINE Cause Hepatic cytolysis? 11 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hepatic cytolysis have been filed in association with ESKETAMINE (Spravato). This represents 0.1% of all adverse event reports for ESKETAMINE.
11
Reports of Hepatic cytolysis with ESKETAMINE
0.1%
of all ESKETAMINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hepatic cytolysis From ESKETAMINE?
Of the 11 reports, 1 (9.1%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESKETAMINE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ESKETAMINE Cause?
Dissociation (3,103)
Sedation (2,244)
Suicidal ideation (1,254)
Drug ineffective (1,005)
Nausea (807)
Depression (800)
Anxiety (659)
Hospitalisation (657)
Product dose omission issue (635)
Hypertension (605)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which ESKETAMINE Alternatives Have Lower Hepatic cytolysis Risk?
ESKETAMINE vs ESLICARBAZEPINE
ESKETAMINE vs ESMOLOL
ESKETAMINE vs ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\NAPROXEN